Whats Changing in 2026 Heres a breakdown of the new changes starting Jan
GSH augmentation deserves investigation as a beneficial therapeutic approach for not only PD but also numerous other CNS disorders for which GSH deficiency and GSH-related enzyme deficits have been documented (multiple sclerosis, 25,26 autism, 2729 Alzheimers disease, 30,31 schizophrenia, 32,33 and bipolar disease 34 )
According to recent reports, SIRT1 contributes to cellular lifespan extension, resistance to oxidative stress, and repair of DNA damage (Elshazly et al
Studies confirm that semaglutide pharmacokinetics remain consistent whether administered fasting or fed
Fiber-rich foods, higher-protein meals, and fermented foods are each linked in research to greater GLP-1/PYY responses or a more diverse microbiome